Cargando…
Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis
INTRODUCTION: Basal-like breast cancer (BLBC) is an aggressive subtype often characterized by distant metastasis, poor patient prognosis, and limited treatment options. Therefore, the discovery of alternative targets to restrain its metastatic potential is urgently needed. In this study, we aimed to...
Autores principales: | Papageorgis, Panagiotis, Ozturk, Sait, Lambert, Arthur W., Neophytou, Christiana M., Tzatsos, Alexandros, Wong, Chen K., Thiagalingam, Sam, Constantinou, Andreas I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531803/ https://www.ncbi.nlm.nih.gov/pubmed/26208975 http://dx.doi.org/10.1186/s13058-015-0607-y |
Ejemplares similares
-
Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis
por: Kalli, Maria, et al.
Publicado: (2019) -
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
por: Neophytou, Christiana, et al.
Publicado: (2018) -
Integrin Signaling in Mammary Epithelial Cells and Breast Cancer
por: Lambert, Arthur W., et al.
Publicado: (2012) -
Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy
por: Neophytou, Christiana M., et al.
Publicado: (2019) -
Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report
por: Shimodaira, Yosuke, et al.
Publicado: (2021)